In the Chinese medical devices industry, there were 9 M&A deals announced in Q2 2023, worth a total value of $193.5m, according to GlobalData’s Deals Database. The $100m minority acquisition of future health by rothschild investment was the industry’s largest disclosed deal. A thorough analysis of the disruptive themes, the M&A activity and most notable deals are included in GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes report. Buy the report here.
In value terms, M&A activity in China increased by 19% in Q2 2023 compared with the previous quarter’s total of $162.5m and fell by 68% as compared to Q2 2022. Related deal volume increased by 13% in Q2 2023 versus the previous quarter and was 10% lower than in Q2 2022.
The top-ranked legal advisorss supporting these M&A deals in China Q2 2023 were Dechert; Ropes & Gray with 1, 1 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers and Acquisitions Deals by Top Themes, buy the report here.